Drug
Tiragolumab
Tiragolumab: highest development phase Phase 3, developed by Roche. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tiragolumab NCT04294810 | Phase 3 | Non-Small Cell Lung Cancer |
Latest
No recent events.
Follow Tiragolumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.